Literature DB >> 12454007

Role of the ErbB-4 carboxyl terminus in gamma-secretase cleavage.

Chang-Yuan Ni1, Hongping Yuan, Graham Carpenter.   

Abstract

The ErbB-4 receptor tyrosine kinase has a PDZ domain recognition motif at its carboxyl terminus. The first step in ErbB-4 proteolytic processing is a metalloprotease-dependent cleavage of the receptor ectodomain, which is not influenced by deletion of this motif. Metalloprotease cleavage of ErbB-4 produces a membrane-associated 80-kDa fragment that is a substrate for subsequent gamma-secretase cleavage, which releases the cytoplasmic domain from the membrane and allows nuclear translocation of this fragment. Deletion of the PDZ domain recognition motif does abrogate the gamma-secretase cleavage of ErbB-4. The wild-type 80-kDa ErbB-4 fragment forms an association complex with presenilin, thought to be the catalytic moiety of gamma-secretase activity. However, this association is significantly impaired by loss of the PDZ domain recognition motif from ErbB-4. Deletion of this ErbB-4 motif prevents the nuclear localization of the ErbB-4 cytoplasmic domain. Data also show that the basal cleavage of wild-type ErbB-4 by this proteolytic system can produce a sufficient level of ErbB-4 processing to negatively influence cell growth and that loss of the PDZ domain recognition motif abrogates this response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454007     DOI: 10.1074/jbc.M210504200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  On the molecular basis of the receptor mosaic hypothesis of the engram.

Authors:  Luigi F Agnati; Sergi Ferré; Giuseppina Leo; Carme Lluis; Enric I Canela; Rafael Franco; Kjell Fuxe
Journal:  Cell Mol Neurobiol       Date:  2004-08       Impact factor: 5.046

Review 2.  Receptor tyrosine kinases in the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

Review 3.  Nuclear mode of the EGFR signaling network: biology, prognostic value, and therapeutic implications.

Authors:  Hui-Wen Lo
Journal:  Discov Med       Date:  2010-07       Impact factor: 2.970

Review 4.  Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations.

Authors:  Woody Han; Hui-Wen Lo
Journal:  Cancer Lett       Date:  2012-01-17       Impact factor: 8.679

Review 5.  Cellular stress reactions as putative cholinergic links in Alzheimer's disease.

Authors:  Debra Toiber; Hermona Soreq
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

Review 6.  The role of ADAM17 in tumorigenesis and progression of breast cancer.

Authors:  Hongyu Shen; Liangpeng Li; Siying Zhou; Dandan Yu; Sujin Yang; Xiu Chen; Dandan Wang; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  Tumour Biol       Date:  2016-09-22

7.  The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.

Authors:  Rebecca S Muraoka-Cook; Melissa Sandahl; Carty Husted; Debra Hunter; Leah Miraglia; Shu-mang Feng; Klaus Elenius; H Shelton Earp
Journal:  Mol Biol Cell       Date:  2006-07-12       Impact factor: 4.138

8.  Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue.

Authors:  Kenneth H Minor; Juan C Bournat; Nicole Toscano; Roman J Giger; Stephen J A Davies
Journal:  Brain       Date:  2010-11-28       Impact factor: 13.501

Review 9.  Targeting the EGFR signaling pathway in cancer therapy.

Authors:  Parthasarathy Seshacharyulu; Moorthy P Ponnusamy; Dhanya Haridas; Maneesh Jain; Apar K Ganti; Surinder K Batra
Journal:  Expert Opin Ther Targets       Date:  2012-01-12       Impact factor: 6.902

Review 10.  Trafficking of receptor tyrosine kinases to the nucleus.

Authors:  Graham Carpenter; Hong-Jun Liao
Journal:  Exp Cell Res       Date:  2008-10-11       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.